Los Angeles Capital Management LLC Acquires 4,991 Shares of PetIQ, Inc. (NASDAQ:PETQ)

Posted by on Aug 9th, 2023

Los Angeles Capital Management LLC increased its holdings in PetIQ, Inc. (NASDAQ:PETQ – Free Report) by 17.3% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 33,886 shares of the company’s stock after buying an additional 4,991 shares during the period. Los Angeles Capital Management LLC owned about 0.12% of PetIQ worth $388,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of PETQ. Capital Research Global Investors raised its stake in PetIQ by 199.5% in the first quarter. Capital Research Global Investors now owns 1,051,358 shares of the company’s stock worth $25,653,000 after buying an additional 700,358 shares in the last quarter. Premier Fund Managers Ltd bought a new position in PetIQ in the fourth quarter worth approximately $3,097,000. UBS Group AG raised its stake in PetIQ by 1,160,571.4% in the fourth quarter. UBS Group AG now owns 243,741 shares of the company’s stock worth $2,247,000 after buying an additional 243,720 shares in the last quarter. Marshall Wace LLP raised its stake in PetIQ by 67.3% in the fourth quarter. Marshall Wace LLP now owns 496,540 shares of the company’s stock worth $4,578,000 after buying an additional 199,828 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in PetIQ by 46.0% in the fourth quarter. AQR Capital Management LLC now owns 481,710 shares of the company’s stock worth $4,441,000 after buying an additional 151,876 shares in the last quarter. Institutional investors own 88.57% of the company’s stock.

PetIQ Stock Performance

Shares of NASDAQ:PETQ opened at $17.41 on Wednesday. The firm has a 50 day moving average of $15.17 and a 200 day moving average of $12.81. The company has a market capitalization of $511.51 million, a price-to-earnings ratio of -12.09, a price-to-earnings-growth ratio of 5.25 and a beta of 2.01. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 1.98. PetIQ, Inc. has a 52 week low of $6.66 and a 52 week high of $18.19.

PetIQ (NASDAQ:PETQ – Get Free Report) last issued its quarterly earnings data on Tuesday, May 9th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.25 by $0.13. PetIQ had a positive return on equity of 8.91% and a negative net margin of 4.45%. The firm had revenue of $290.47 million during the quarter, compared to analyst estimates of $278.69 million. On average, sell-side analysts predict that PetIQ, Inc. will post 0.41 earnings per share for the current fiscal year.

PetIQ Profile

(Free Report)

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications.

Featured Stories

Want to see what other hedge funds are holding PETQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetIQ, Inc. (NASDAQ:PETQ – Free Report).

Institutional Ownership by Quarter for PetIQ (NASDAQ:PETQ)

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.